Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Anika Therapeutics, Inc. (NASDAQ: ANIK)
ANIK Stock Predictions and Ratings
WSX Rating:
HOLD
WSX Forecast (1yr):
2.10%
Analyst Rating:
BUY
Analyst Forecast (1yr):
-40.90%
ANIK Stock Analysis
ANIK
PE Ratio:
ANIK
PEG Ratio:
Not Available
ANIK
Forward EPS Growth (12 month):
0.00%
ANIK
PS Ratio:
1.6
ANIK
PSG Ratio:
0.2
ANIK
Forward Revenue Growth (12 month):
6.70%
ANIK Articles
No data was found